6620Handa Pharmaceuticals6620 info
$2.41info-1.28%24h
Global rank13879
Market cap$340.21M
Change 7d-5.04%
YTD Performance-58.27%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Handa Pharmaceuticals (6620) Stock Overview

    Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027, an oncology products. In addition, the company develops HND-004, a diabetic drug; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pharmaceuticals, Inc. was founded in 2014 and is headquartered in Tainan City, Taiwan.

    6620 Stock Information

    Symbol
    6620
    Address
    No.23, Nanke 3rd RoadTainan City, 74147Taiwan
    Founded
    -
    Trading hours
    -
    Website
    https://www.handapharma.com.tw
    Country
    🇹🇼 Taiwan
    Phone Number
    886 6 505 7508

    Handa Pharmaceuticals (6620) Price Chart

    -
    Value:-

    Handa Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.41
    N/A
    Market Cap
    $340.21M
    N/A
    Shares Outstanding
    140.94M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org